CTXR Dividend History & Analysis | 0% Yield
CTXR has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 644 M | 7.99% | 11.0% |
| PFE | 141,343 M | 7.02% | 6.23% |
| GS71 | 83,017 M | 5.01% | 6.50% |
| BMY | 94,037 M | 5.08% | 5.14% |
| SAN | 116,341 M | 4.66% | 5.40% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,093 M | 22.9% | 100% |
| ZTS | 65,352 M | 16.7% | 100% |
| LLY | 677,175 M | 11.9% | 99.5% |
| SIGA | 644 M | 10.1% | 98.8% |
| MRK | 212,686 M | 5.69% | 98.5% |
Similar Stocks with Attractive Dividends - Compare CTXR Dividends with its Peer-Group
7.99% Yield
3.89% Yield
4.66% Yield
3.42% Yield
3.07% Yield
2.52% Yield
CTXR Dividend History: as of September 2025
No dividends paid yet.CTXR Dividend FAQ
Citius Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in developing and commercializing critical care products, with a focus on addressing unmet medical needs. The companys lead product, LYMPHIR, is an FDA-approved targeted immunotherapy for treating cutaneous T-cell lymphoma, a rare and debilitating disease. Citius Pharmaceuticals has a robust pipeline, including Mino-Lok, an antibiotic lock solution designed to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation aimed at relieving hemorrhoid symptoms. Both Mino-Lok and Halo-Lido have undergone significant clinical trials, with the Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido having been completed.
What is the Dividend Yield of CTXR?
As of September 2025, CTXR`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 1.18.Does CTXR pay a dividend?
As of September 2025 CTXR does not pay a dividend.How often does CTXR pay dividends?
Over the last 12 months, CTXR has issued dividend payments.Will CTXR pay dividends in 2025?
The next Ex-Dividend date for Citius Pharmaceuticals (CTXR) is currently unknown.What is the next Ex-Dividend Date for CTXR?
The next Ex-Dividend date for Citius Pharmaceuticals (CTXR) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CTXR?
CTXR's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CTXR?
CTXR's 5-Year Yield on Cost is -%. If you bought CTXR's shares at 25.50 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CTXR?
CTXR Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CTXR have a good Dividend Yield?
CTXR`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CTXR?
The Dividend Payout Ratio of CTXR is unknown.What is the Dividend Rating of CTXR?
CTXR`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-09-16 04:04